The current valuation score of Fennec Pharmaceuticals Inc is 9.27, ranking 26 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -32.69, which is -440.55% below the recent high of 111.31 and -1244.81% above the recent low of -439.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.